Urolithin A attenuates diabetic kidney disease by inhibiting ferroptosis via activation of the Nrf2/HO-1 signaling pathway
Cell Biology and Toxicology · 18.11.2026
DOI: 10.1007/s10565-026-10342-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biology and Toxicology, online erschienen am 18.11.2026. Verfasst von Zhuan Peng und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Hubei Province, Natural Science Foundation of Enshi Tujia and Miao Autonomous Prefecture Government,China.
Abstract (Originalsprache)
Ferroptosis, an iron-dependent form of regulated cell death driven by lipid peroxidation, plays a critical role in renal tubular injury in diabetic kidney disease (DKD). Nuclear factor erythroid 2-related factor 2 (Nrf2) is a central regulator of cellular redox homeostasis and lipid peroxidation, thereby exerting a pivotal influence on ferroptosis. Urolithin A (UA), a gut microbiota-derived metabolite, exhibits potent antioxidant and anti-glycation properties and has demonstrated protective effects in diabetic models. This study aimed to investigate the renoprotective effects of UA in DKD and to determine whether these effects are mediated through inhibition of ferroptosis via activation of the Nrf2/HO-1 signaling pathway. A DKD model was established using db/db mice, which were randomly assigned to four groups: db/m , db/m + UA, db/db , and db/db + UA. After 10 weeks of UA administration by gavage, renal function, histopathological changes, and markers of oxidative stress and ferroptosis were evaluated. In vitro, HK-2 cells were exposed to high glucose to mimic the diabetic milieu, followed by UA treatment to assess cellular injury and associated molecular alterations. The involvement of the Nrf2 pathway was further validated by siRNA-mediated knockdown of Nrf2. UA significantly improved renal function in db/db mice, as indicated by decreased blood urea nitrogen and urinary albumin-to-creatinine ratio (UACR), along with marked attenuation of renal histopathological damage. UA effectively suppressed oxidative stress both in vivo and in vitro, as evidenced by reduced levels of reactive oxygen species (ROS) and malondialdehyde (MDA), and increased glutathione (GSH) content. Furthermore, UA modulated ferroptosis-related proteins by downregulating ACSL4 and upregulating GPX4 and SLC7A11. These effects were accompanied by enhanced nuclear translocation of Nrf2 and increased expression of HO-1. Notably, Nrf2 knockdown largely abrogated the protective effects of UA. UA attenuates the progression of DKD by activating the Nrf2/HO-1 signaling pathway, thereby inhibiting oxidative stress and ferroptosis. These findings suggest that UA may serve as a promising therapeutic candidate for the treatment of DKD.
Förderung
- Natural Science Foundation of Hubei Province
- Natural Science Foundation of Enshi Tujia and Miao Autonomous Prefecture Government,China
Zitieren
APA
Peng, Z., Fang, X., Zhou, C., Sun, G., Qin, B., Xie, W., & Li, W. (2026). Urolithin A attenuates diabetic kidney disease by inhibiting ferroptosis via activation of the Nrf2/HO-1 signaling pathway. Cell Biology and Toxicology. https://doi.org/10.1007/s10565-026-10342-5
Vancouver
Peng Z, Fang X, Zhou C, Sun G, Qin B, Xie W, et al. Urolithin A attenuates diabetic kidney disease by inhibiting ferroptosis via activation of the Nrf2/HO-1 signaling pathway. Cell Biology and Toxicology. 2026. doi:10.1007/s10565-026-10342-5
BibTeX
@article{Peng2026,
author = {Peng, Zhuan and Fang, Xiping and Zhou, Changyu and Sun, Guogen and Qin, Bo and Xie, Weiquan and Li, Weiwei},
title = {Urolithin A attenuates diabetic kidney disease by inhibiting ferroptosis via activation of the Nrf2/HO-1 signaling pathway},
journal = {Cell Biology and Toxicology},
year = {2026},
doi = {10.1007/s10565-026-10342-5}
}
EUVIMED